MetLife Investment Management LLC Sells 145 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
MetLife Investment Management LLC trimmed its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,343 shares of the biopharmaceutical company’s stock after selling 145 shares during the period. MetLife […]
MetLife Investment Management LLC trimmed its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,343 shares of the biopharmaceutical company’s stock after selling 145 shares during the period. MetLife […]
